Cargando…

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants

BACKGROUND: Currently, the dosage of tacrolimus used after transplantation is based on the patient's body weight. However, there is a low correlation between body weight and body composition in kidney transplant recipients. In this study, we evaluate the pharmacokinetics of tacrolimus according...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Seung Seok, Kim, Do Hyoung, Lee, Su Mi, Han, Na Young, Oh, Jung Mi, Ha, Jongwon, Kim, Yon Su
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716096/ https://www.ncbi.nlm.nih.gov/pubmed/26894021 http://dx.doi.org/10.1016/j.krcp.2012.06.007

Ejemplares similares

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function
por: Han, Seung Seok, et al.
Publicado: (2016)

Risk of Graft Failure in Kidney Recipients with Cured Post-Transplant Cancer
por: Kim, Ji Eun, et al.
Publicado: (2020)

Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipients
por: Francke, M. I., et al.
Publicado: (2022)

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
por: Han, Nayoung, et al.
Publicado: (2017)

Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients
por: Ko, Hyunmin, et al.
Publicado: (2021)

Change in Body Compositions of Asian Recipients after Kidney Transplantation
por: Han, Seung Seok, et al.
Publicado: (2012)

Flat Pattern Peaks of Tacrolimus Absorption and Associated Pharmacogenomic Variants in Kidney Transplantation Recipients
por: Kim, Suh Min, et al.
Publicado: (2022)

Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients
por: Sohn, Minji, et al.
Publicado: (2018)

Model based development of tacrolimus dosing algorithm considering CYP3A5 genotypes and mycophenolate mofetil drug interaction in stable kidney transplant recipients
por: Kim, Jae Hyun, et al.
Publicado: (2019)

Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers
por: Kim, Jae Hyun, et al.
Publicado: (2018)

Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
por: Nasiri-Toosi, Zahra, et al.
Publicado: (2014)

Author Correction: Whole exome sequencing for the identification of CYP3A7 variants associated with tacrolimus concentrations in kidney transplant patients
por: Sohn, Minji, et al.
Publicado: (2020)

Deep Learning-Based Quantification of Visceral Fat Volumes Predicts Posttransplant Diabetes Mellitus in Kidney Transplant Recipients
por: Kim, Ji Eun, et al.
Publicado: (2021)

Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome
por: Kim, Ji Eun, et al.
Publicado: (2019)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
por: Mansell, Holly, et al.
Publicado: (2022)

Evaluation of Nutrient Intake in Early Post Kidney Transplant Recipients
por: Rho, Mi Ra, et al.
Publicado: (2013)

Discovery of Biomarkers Related to Interstitial Fibrosis and Tubular Atrophy among Kidney Transplant Recipients by mRNA-Sequencing
por: Lee, Hyun Kyung, et al.
Publicado: (2023)

A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
por: Alloway, R R, et al.
Publicado: (2012)

Association of high intra-patient variability in tacrolimus exposure with calcineurin inhibitor nephrotoxicity in kidney transplantation
por: Kim, Hyokee, et al.
Publicado: (2023)

Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients
por: Tornatore, Kathleen M., et al.
Publicado: (2022)

Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial
por: Han, Ahram, et al.
Publicado: (2019)

Epidermal Cysts in a Tacrolimus Treated Renal Transplant Recipient
por: Ahn, In Su, et al.
Publicado: (2011)

Kidney Transplantation in Sensitized Recipients; A Single Center Experience
por: Kim, Sun Moon, et al.
Publicado: (2009)

Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients
por: Kim, Ji Eun, et al.
Publicado: (2019)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Association between post-transplant red cell distribution width and prognosis of kidney transplant recipients
por: Park, Sehoon, et al.
Publicado: (2017)

Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk
por: Kim, Eun Jin, et al.
Publicado: (2021)

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
por: Marfo, Kwaku, et al.
Publicado: (2010)

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
por: Moes, D. J. A. R, et al.
Publicado: (2015)

A Population Pharmacokinetic Model of Whole-Blood and Intracellular Tacrolimus in Kidney Transplant Recipients
por: Franken, Linda G., et al.
Publicado: (2022)

Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation
por: Mo, Hyejin, et al.
Publicado: (2019)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

Pharmacokinetic Model Based on Stochastic Simulation and Estimation for Therapeutic Drug Monitoring of Tacrolimus in Korean Adult Transplant Recipients
por: Choi, Suein, et al.
Publicado: (2022)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
por: Son, Seung Yeon, et al.
Publicado: (2017)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
por: Thongprayoon, Charat, et al.
Publicado: (2020)

Population pharmacokinetics of immediate‐ and prolonged‐release tacrolimus formulations in liver, kidney and heart transplant recipients
por: Lu, Zheng, et al.
Publicado: (2019)

Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients
por: Martial, Lisa C., et al.
Publicado: (2021)

Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus
por: Hwang, Hyeon Seok, et al.
Publicado: (2010)

Posttransplant Hyponatremia Predicts Graft Failure and Mortality in Kidney Transplantation Recipients: A Multicenter Cohort Study in Korea
por: Han, Seung Seok, et al.
Publicado: (2016)

Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients
por: Baek, Hyunjeong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p55u2f52u5le75f9tpc0u6hvbs